Nano-Based Technology in Glioblastoma

Neoplasms of the central nervous system (CNS) constitute a minor fraction of all malignant tumors. CNS accounts for approximately 4% of newly diagnosed oncological cases. Among primary CNS neoplasms, gliomas predominate, comprising nearly 90% of all malignant brain tumors, with Glioblastoma (GBM) re...

Full description

Bibliographic Details
Published in:Molecules
Main Authors: Dorota Bartusik-Aebisher, Izabela Rudy, Karolina Pięta, David Aebisher
Format: Article
Language:English
Published: MDPI AG 2025-08-01
Subjects:
central nervous system
glioblastoma
nanotechnology
Online Access:https://www.mdpi.com/1420-3049/30/17/3485

Internet

https://www.mdpi.com/1420-3049/30/17/3485

Similar Items